Clinical Trial Update: A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating trilaciclib in combination with chemotherapy for diffuse large B-cell lymphoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Cosela (trilaciclib)
• trilaciclib (trilaciclib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: DLBCL | Phase 2 | Status: RECRUITING